Randomized double-blind comparative study of recombinant human erythropoietin (epoetin kappa, produced by serum-free culture) in renal anemia patients on hemodialysis

Japanese Pharmacology and Therapeutics

Volumn 38, Issue 2, 2010, Pages 181-198

  Akiba, Takashi ^a   Akizawa, Tadao ^b   Kakuma, Tatsuyuki ^c  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KURUME UNIVERSITY   (Japan)

Author keywords

Double blind study; Epoetin kappa; Erythropoietin; Hemodialysis; Renal anemia patients

Indexed keywords

ANTIANEMIC AGENT; EPOETIN KAPPA; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ANEMIA; ANTIBODY PRODUCTION; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURE MEDIUM; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL ANEMIA; SIDE EFFECT; TREATMENT DURATION;

EID: 77949795445     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Japanese source
2. Japanese source
3. Japanese source
4. Maschio G. Erythropoietin and systemic hypertension. Nephrol Dial Transplant 1995 ; 10 (Suppl 2) : 74-9.
5. Japanese source